IDH1 and central nervous system cancer: Eckel-Passow et al. [19] scored tumors according to the IDH mutation, mutations in the TERT (telomerase reverse transcriptase) promoter, and the codeletion of 1p19q in 1087 gliomas and 11590 controls.